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HCCK the Bmax values being 121550±45550 and 84880±5380 sites/cell,
respectively. From these data the calculated KD values were 1.1±0.06
(HFLS) and 3.1±1.7 (HCCK) nM. Inhibition curves were performed with
antagonists (1 pM-1mM) or unlabelled BK at the [3H]BK binding (1.5 nM).
Ki values for BK were 0.93±0.12 (HFLS) and 0.83±0.12 (HCCK) nM.
Both antagonists displayed high afﬁnity values: MEN16132 Ki values of
1.35±0.05 and 1.75±0.35 nM in HFLS and HCCK, respectively, and icati-
bant was 3- to 5-fold less potent, Ki values being 4.6±1.7 and 8.8±2.9 nM.
BK induced IP accumulation both in HFLS (EC50 0.73±0.08 nM) and
HCCK (EC50 0.64±0.05 nM), and the induced maximal effect was 11±3
(HFLS) and 15±1.5 (HCCK) fold over the basal response. The antag-
onists potency was evaluated by preincubating cells with MEN16132
or icatibant at different concentrations (0.1 nM-10 mM) for 15min before
the agonist concentration-response curve (0.03 nM-100mM). Both antag-
onists displayed a concentration-dependent antagonism, by shifting to the
right the BK curve, but MEN16132 displayed a greater potency in respect
to icatibant. The calculated pKB values were 9.93±0.09 (HFLS) and
10.44±0.16 (HCCK) for MEN16132, and 8.1±0.03 (HFLS) and 8.2±0.16
(HCCK) for icatibant.
Conclusions: This is the ﬁrst study quantifying B2 receptors, the afﬁnity
and potency of BK and its antagonists in HCCK. Current data highlight
the pharmacological proﬁle of MEN16132 as a very potent bradykinin
antagonist, in respect with icatibant, both in HFLS and HCCK.
433 MOLECULAR AND CELLULAR MECHANISMS REGULATING
CROSS-TALK BETWEEN THE CYCLOOXYGENASE AND
LIPOXYGENASE BIOSYNTHETIC AXES
B. Zhai, Q. He, J. Di Battista. McGill University, Montreal, QC, CANADA
Purpose: Our principal objective is to deﬁne potential cellular and
molecular interactions between inﬁltrating mast cells/mast-cell derived in-
ﬂammatory mediators and resident human synovial ﬁbroblasts ultimately
contributing to disease pathophysiology.
Methods:
1. Cultured human synovial ﬁbroblasts (HSF) were obtained from
osteoarthritis-affected synovial membranes.
2. Western and Northern blot analyses were used to measure protein
and mRNA expression, respectively.
3. Transient transfection assays were employed to express activated
signaling molecules and/or dominant negative mutants and to analyze
the reporter luciferase activity. A Mek1/2 inhibitor is also included in
this reporter luciferase activity study.
4. Prostaglandin E2 and leukotriene B4 levels were quantiﬁed by ELISA.
5. Statistical analyses included Student’s T-test and ANOVA.
Results:
1. Leukotriene B4 stabilized cyclooxygenase-2 mRNA and cyclooxygen-
ase-2 protein levels in Il-1b-treated human synovial ﬁbroblasts, leading
to the increase of prostaglandin E2 production.
2. Leukotriene B4 stabilized cyclooxygenase-2 mRNA on post-
transcriptional level through the cyclooxygenase-2 mRNA 3′-UTR re-
gion in Il-1b-treated human synovial ﬁbroblasts. There is no transcrip-
tional regulation in this stabilization effect of leukotriene B4.
3. Leukotriene B4 exerts this stabilization through Raf/MEK1/ERK1/2
signaling pathway in Il-1b-treated human synovial ﬁbroblasts.
4. The AU-containing proximal region of cyclooxygenase-2 mRNA 3′-
UTR is more important for this stabilization effect of leukotriene B4
in Il-1b-treated human synovial ﬁbroblasts than more distal AU rich
sequences.
Conclusions: The pathogenic mechanisms responsible for arthritis re-
main poorly understood both systemically and in the microenvironment of
the diarthrodial joint. Mast cells are detected in the synovial membrane of
osteoarthritis patients. We demonstrate the potential cellular and molec-
ular interactions between mast cells and mast-cell derived inﬂammatory
mediators and resident human synovial ﬁbroblasts. We hypothesize that
mast-cell derived leukotrienes contribute to synovial inﬂammation through
stabilization of synoviocyte cyclooxygenase-2 expression.
434 ELECTROMAGNETIC FIELDS AND ADENOSINE RECEPTORS
IN CHONDROCYTES AND SYNOVIAL FIBROBLASTS
M. De Mattei1, K. Varani2, F.F. Masieri1, A. Ongaro1, F. Vincenzi2,
P.A. Borea2, A. Caruso1, M. Fini3, S. Setti4, R. Cadossi4. 1Department
of Morphology and Embriology, University of Ferrara, Ferrara, ITALY ,
2Department of Clinical and Experimental Medicine, University of
Ferrara, Ferrara, ITALY, 3Department of Experimental Surgery, Rizzoli
Orthopaedic Institute, Bologna, ITALY, 4Igea Clinical Biophysics, Carpi,
Modena, ITALY
Purpose: Inﬂammation plays an important role in promoting articular car-
tilage damage in joint diseases such as osteoarthritis (OA). Chondrocytes
and synovial ﬁbroblasts (SFs) are involved in joint inﬂammation by releas-
ing biochemical mediators (NO, prostaglandins) and pro-inﬂammatory
cytokines which lead to the decrease of chondrocyte anabolic activity
and the increase of extracellular matrix degradation. Therefore, to prevent
cartilage damage, therapies should aim both to enhance chondrocyte
anabolic activity and to control inﬂammation. Electromagnetic ﬁelds
(EMFs) stimulate anabolic activities in cartilage explants and prevent the
catabolic effect of the inﬂammatory cytokine Il-1. In vivo EMFs retard the
development of OA lesions in guinea pigs; in humans they have been
successfully used for the treatment of OA. Adenosine is known to reduce
inﬂammation in several models by interacting with four receptors (A1,
A2A, A2B and A3). The role of adenosine for managing joint inﬂammation
has been recently documented and drugs with adenosine A2A receptor
agonist activity have shown chondroprotective effects. The aim of this
study was to investiga the potential anti-inﬂammatory activities of EMFs
by the characterization of their effects on adenosine receptors in bovine
chondrocytes and SFs. The functional interaction among adenosine A2A
analogs and EMFs in SFs was analyzed by evaluating the production of
cAMP, an intracellular mediator, the release of prostaglandin E2 (PGE2)
and cyclooxygenase-2 (COX-2) expression.
Methods: Chondrocytes and SFs isolated from bovine articular joints
were cultured in vitro. The effects of EMFs (1.5 mT, 75Hz) on adenosine
receptors were investigated by saturation and competition binding experi-
ments. Adenylyl cyclase assays were performed to evaluate cAMP levels
induced by the A2A agonist, CGS 21680 (2-[p-(2-carboxyethyl)-phenetyl-
amino]-5′-N-ethyl-carboxamido adenosine) and the A2 agonist, NECA (5′-
N-ethyl-carboxamido adenosine) in the absence and in the presence of
EMFs. CGS 21680 and NECA were added to SFs untreated or treated
with TNF-alpha (10 ng/ml) in the absence or in the presence of EMFs.
PGE2 release was measured by immunoassay and COX-2 expression
was evaluated by RT-PCR.
Results: EMFs evoke the upregulation of the A2A and A3 receptors in
both SFs and chondrocytes. The increase in A2A receptor density (1.9 and
2.4 folds, p< 0.01 respectively in chondrocytes and SFs) was associated
to an increase in cAMP levels indicating the functionality of the receptors
in EMF-exposed cells. TNF-alpha stimulated PGE2 release in SFs. CGS
21680 and NECA signiﬁcantly inhibited PGE2 production respectively of
49% and 55%; EMFs inhibited PGE2 release of 63% (vs. TNF-alpha,
p< 0.01) and strongly enhanced the inhibition induced by the agonists.
Modiﬁcation of COX-2 expression mirrored changes in PGE2 levels.
Conclusions: This study supports anti-inﬂammatory activity of EMFs
mediated by an up-regulation of A2A receptors and shows a molecular
action mechanism by which EMFs act. The in vitro EMF anti-inﬂammatory
activity is consistent with the decrease in inﬂammatory cytokines expres-
sion in the articular cartilage of OA animals. Noteworthy, the biophysical
modulation of adenosine pathways has been used in humans as a
therapeutic intervention to control the inﬂammatory microenvironment in
in arthroscopic procedures.
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MOBILITY GROUP BOX CHROMOSOMAL PROTEIN 1 IN
OSTEOARTHRITIC SYNOVIOCYTES
I. Garcı´a-Arnandis1, I. Guille´n2, A. Bru3, M. Alcaraz1. 1University
of Valencia. Department of Pharmacology, Valencia, SPAIN,
2Cardenal-Herrera CEU University, Moncada, SPAIN, 3Department of
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SPAIN
Purpose: The production of inﬂammatory mediators may contribute to
osteoarthritis (OA) pathology. High mobility group box chromosomal pro-
tein 1 (HMGB1) acts as a pro-inﬂammatory cytokine in a wide range of
cells and binds to the receptor for advanced glycation products (RAGE), a
pathway leading to catabolic responses in articular tissues. Of particular
interest in the regulation of inﬂammatory and catabolic processes is the
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heme oxygenase-1 (HO-1) pathway, which is able to counteract cellular
stress in vitro and in vivo. The present study was aimed at identifying a
possible regulatory effect of HO-1 on HMGB1 in OA synoviocytes.
Methods: Synovial tissue samples were obtained from 15 OA patients
undergoing total knee joint replacement. Synoviocytes (ﬁbroblasts and
macrophage-like) were obtained by digestion with collagenase IA, cul-
tured in third passage and treated with interleukin-1b (Il-1b, 100U/ml) for
24 h. HO-1 was induced by treatment with cobalt protoporphyrin IX (CoPP,
10mM). Matrix metalloproteinase (MMP) activity was determined by ﬂuo-
rometric procedures and HMGB1 release by ELISA. Protein expression
was studied by Western blot.
Results: Basal expression of HMGB1 protein was reduced by HO-1
induction in OA synoviocytes. In addition, HMGB1 release into the
medium was signiﬁcantly decreased. Stimulation of synoviocytes with
Il-1b resulted in an enhancement of HMGB1 cellular content and release.
Our results indicate that both processes are down-regulated by HO-1
overexpression. In addition, HO-1 reduced RAGE expression in these
cells. The effects of HO-1 induction were prevented when synoviocytes
were transfected with a siRNA speciﬁc for human HO-1. In cells without
HO-1 induction, HO-1 gene silencing resulted in the up-regulation of
HMGB1 and RAGE. Regulation of HMGB1 by HO-1 was accompanied
by the inhibition of MMP activity in synoviocytes stimulated with Il-1b.
Conclusions: Our data provide evidence that HO-1 can regulate HMGB1
in OA synoviocytes. Overall, HO-1 signaling appears to be an appropriate
target for the development of novel therapies affecting articular disorders.
436 EFFECT OF EPIGALLOCATECHIN GALLATE ON THE
INFLAMMATORY RESPONSE OF Il-1-EXPOSED SYNOVIAL
FIBROBLASTS
P. Sfriso, F. Oliviero, A. Scanu, R. Luisetto, U. Fiocco, L. Punzi.
University of Padova, Padova, ITALY
Purpose: Inﬂammation is increasingly recognized as contributing to the
symptoms and progression of osteoarthritis (OA). Synovitis is a factor
that likely contributes to dysregulation of chondrocyte function, favoring
an imbalance between the catabolic and anabolic activities of the chon-
drocyte in remodeling the cartilage. In recent years, signiﬁcant interest
has emerged in the beneﬁcial health effects attributed to the green tea
polyphenols. Polyphenols in green tea are potent antioxidants, with the
majority of the beneﬁcial effects elicited by epigallocatechin-3-gallate
(EGCG), one of the main constituent of green tea.
Among several inﬂammatory mediators, interleukin-1beta (Il-1) plays a
pivotal role in the pathophysiology of OA. We therefore assessed the
effect of EGCG on the production of interleukin-8 (Il-8) and interleukin-1
receptor antagonist (Il-1ra) in primary cultured synovial ﬁbroblasts stimu-
lated with Il-1.
Methods: Human synovial ﬁbroblasts were stimulated for 24 hours with
Il-1 (10 ng/ml) in the presence or absence of EGCG (0.1−5 mM).
The levels of Il-8 and Il-1ra were measured in cell supernatants by
enzyme-linked immunoassay methods. The lack of cell cytotoxicity of
EGCG was ensured using the colorimetric MTT assay.
Results: Treatment of synovial ﬁbroblasts with EGCG resulted in a
marked inhibition of Il-1-induced Il-8 production. EGCG also increased in
a dose-dependent manner the release of Il-1ra by stimulated ﬁbroblasts.
Conclusions: The present study shows that EGCG, at dose comparable
with plasma concentration achieved by the consumption of two cups of
tea, suppressed the inﬂammatory response of Il-1-exposed synovial ﬁ-
broblasts. The suppressive effect of EGCG may be due to the interference
with inﬂammatory signal transduction pathway or may be related to the
inhibition of the release and the accumulation of reactive oxygen species.
Our ﬁndings suggest that EGCG may be of potential therapeutic value in
the treatment of OA.
437 EFFECT OF EPIGALLOCATECHIN GALLATE ON CALCIUM
CRYSTAL-INDUCED CHEMOTACTIC FACTORS
F. Oliviero, P. Sfriso, A. Scanu, M. Miorin, U. Fiocco, C. Sales,
P. Spinella, L. Punzi. University of Padova, Padova, ITALY
Purpose: Although osteoarthritis (OA) is deﬁned as a cartilage disease,
synovitis involving mononuclear cell inﬁltration and overexpression of
proinﬂammatory mediators is common in early and late OA. Calcium
crystals deposition is a factor that likely contributes to synovial membrane
inﬂammation.
Polyphenols in green tea are potent antioxidants, with the majority of the
beneﬁcial effects elicited by epigallocatechin-3-gallate (EGCG), one of
the main constituent of green tea. The aim of our study was to evaluate if
EGCG may inﬂuence some inﬂammatory aspects of OA. To this aim we
studied the effect of EGCG on chemotactic factors released by human
ﬁbroblasts stimulated with calcium crystals, regular features of the most
severe forms of OA.
Methods: Human synovial ﬁbroblasts were stimulated with pyrophos-
phate dihydrate (CPPD) and basic calcium phosphate (BCP) crystals
(0.01−0.1mg/ml) in the presence or absence of EGCG (0.1−5mM).
Il-1beta (10 ng/ml) was used as a positive control.
CPPD and BCP crystals were synthesized by the methods of Cheng
and McCarthy respectively. The levels of MCP-1 were measured in cell
supernatants by enzyme-linked immunoassay methods. The chemotactic
effect of culture supernatants was evaluated on chemotaxis chamber by
the migration of fresh-isolated mononuclear blood cells. The lack of cell
cytotoxicity of both EGCG and calcium crystals was ensured using the
colorimetric MTT assay.
Results: EGCG inhibited MCP-1 release by stimulated ﬁbroblasts in a
dose-dependent manner. Supernatants of crystals-stimulated cells loose
their ability to induce mononuclear cell migration when EGCG was added
in the medium. EGCG inhibited both MCP-1 release and supernatants
chemotactic activity of Il-1beta stimulated culture in a dose-dependent
manner.
Conclusions: The present study shows that EGCG, at dose comparable
with plasma concentration achieved by the consumption of two cups
of tea, modify the inﬂammatory response of calcium crystal-exposed
synovial ﬁbroblasts. EGCG may interfere with inﬂammatory signal trans-
duction pathway and may also inhibits the cellular generation, the release
and the accumulation of reactive oxygen species. Our results suggest
that EGCG might represents a good candidate for the prevention and
treatment of OA.
438 MODULATION OF THE INFLAMMATORY AND CATABOLIC
RESPONSE BY PROSTAGLANDIN E2 (PGE2) IS PARTIALLY
DEPENDENT ON THE INDUCTION OF DUAL SPECIFICITY
PHOSPHATASE 1 (DUSP-1) IN VITRO AND IN VIVO
Q. He, B. Zhai, A. Mancini, J.A. Di Battista. McGill University, Montreal,
QC, CANADA
Purpose: Prostaglandin E2 (PGE2) is an eicosanoid with pleiotropic
properties that binds G-protein coupled receptors, effecting changes in
cell signalling through activation of protein kinases and phosphatases. We
examined PGE2-dependent control of the dual speciﬁcity phosphatase-1
(DUSP-1) in arthritis-affected human synovial ﬁbroblasts (HSF) in culture
and in the dorsal air-pouch mouse model of synovial inﬂammation in vivo.
Methods:
• Cultured human synovial ﬁbroblasts (HSF) were obtained by sequential
enzymic digestion from osteoarthritis-affected synovial membranes.
• Western and Northern blot analyses were used to measure protein,
phosphorylated protein and mRNA expression, respectively.
• Transient transfection assays were employed to express activated sig-
naling molecules, shRNA constructs, and to analyze reporter luciferase
activity.
• Wild type and DUSP-1 null mice were used in the dorsal air pouch
studies. Analytes were measured by ELISA and RT-PCR. Cell inﬁltra-
tion measurements were assessed by ﬂow cytometry.
• Statistical analyses included Student’s T-test and ANOVA
Results: PGE2 induced a robust (7 fold) and rapid (10min) increase in
DUSP-1 mRNA in cultured HSF, reaching a zenith at 30−60min followed
by decay to control levels. A late phase of DUSP-1 mRNA expression was
observed after 4 h and continued for another 20 h. In transient transfection
assays using a DUSP-1 promoter-luciferase reporter construct or a lu-
ciferase reporter construct harbouring the DUSP-1 mRNA 3′-UTR region
fused 3′ prime, PGE2 induced a modest (1.38) increase in promoter
(transcriptional) activity while also stabilizing luciferase-DUSP-1 3′UTR
mRNA chimeric transcripts (2.6 fold; post-transcriptional regulation). With
respect to DUSP-1 protein, PGE2 induced a similar bi-phasic pattern as
observed with DUSP-1 mRNA, appearing within 20−30min, a plateau at
60min, with protein levels declining to near control levels. A second phase
of protein expression was observed from 4h and DUSP-1 protein was
still detectable after 24 h. In terms of measuring DUSP-1 phosphatase
activity, PGE2 abrogated rhIl-1b induced phosphorylation of T183/Y185
of SAPK/JNK, a response abolished by knock down of DUSP-1 through
targeting by over expression with either a shRNA expression construct or
the DUSP-1 inhibitor sanquinarine sulfate. Using speciﬁc PGE2 receptor
(EP) agonists and antagonists, we observed that the PGE2-dependent
